|
|
|
Volumn 4, Issue 140, 2008, Pages 144-149
|
|
Osteoporosis;Ostéoporose
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASEDOXIFENE;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
CATHEPSIN K;
CATHEPSIN K INHIBITOR;
MK 0822;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
PLACEBO;
RALOXIFENE;
RISEDRONIC ACID;
SCLEROSTIN;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
STRONTIUM RANELATE;
TAMOXIFEN;
UNCLASSIFIED DRUG;
VITAMIN D;
ZOLEDRONIC ACID;
BONE DENSITY;
BONE NECROSIS;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG SAFETY;
HIP FRACTURE;
HUMAN;
MAXILLA;
OSTEOPOROSIS;
PAGET BONE DISEASE;
PATIENT COMPLIANCE;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
RISK REDUCTION;
SURVIVAL;
SWITZERLAND;
TREATMENT OUTCOME;
VERTEBRA DISLOCATION;
BONE DENSITY CONSERVATION AGENTS;
CATHEPSINS;
HUMANS;
OSTEOCLASTS;
OSTEOPOROSIS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
|
EID: 39749188171
PISSN: 16609379
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (16)
|
